Search
Search Results
-
The governance of imported 2019-nCov infections: What can be learned from China’s experience?
Delta and Omicron variants of 2019-nCoV are still spreading globally, and many imported infections have been identified in China as well. In order to...
-
Maintaining proper health records improves machine learning predictions for novel 2019-nCoV
BackgroundAn ongoing outbreak of a novel coronavirus (2019-nCoV) pneumonia continues to affect the whole world including major countries such as...
-
2019-nCOV distress and depressive, anxiety and OCD-type, and eating disorder symptoms among postpartum and control women
This study compared postpartum and control women on depressive, anxiety, and OCD-type symptoms, and eating disorder symptoms during the 2019-nCOV...
-
The pandemic characteristics of 2019-nCoV: case-control study for severity and geographic locations for 2019-nCoV epidemics worldwide
Using available official data we found 248 epidemics curves caused worldwide by the 2019-nCoV in the period December 2019–March 31st 2020. The...
-
Negative Predictive Value of the Rapid Test Ag 2019-nCoV During the Predominance of Omicron over the Delta Variant and Implications in the Emergency Department
The high prevalence of asymptomatic patients infected with SARS-CoV-2 during the pandemic peaks and the common occurrence of in-hospital transmission...
-
2019-nCoV effects, transmission and preventive measures: an overview
AimCOVID-19 has led to a global crisis not only in the health sector but also in the economic, social and education sectors, as well as the lives of...
-
Management of Parkinson's disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV
IntroductionDeep brain stimulation (DBS) is an effective treatment for patients with Parkinson’s disease (PD). On time follow-up and timely...
-
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named “2019 novel coronavirus (2019-nCoV)” by the...
-
The status and high risk factors of severe psychological distress in migraine patients during nCOV-2019 outbreak in Southwest China: a cross-sectional study
BackgroundPsychological distress is highly prevalent among migraineurs during public health emergencies. The coronavirus disease 2019 (nCOV-2019) has...
-
Current efforts and challenges facing responses to 2019-nCoV in Africa
The novel coronavirus is a pandemic that has started to creep into Africa thus making the virus a truly global, health security threat. The number of...
-
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions
The outbreak of a novel coronavirus disease (COVID-19, caused by the 2019-nCoV infection) in December 2019 is one of the most severe public health...
-
Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients
A global health emergency has been declared by the World Health Organization as the 2019-nCoV outbreak spreads across the world, with confirmed...
-
Impact of international travel dynamics on domestic spread of 2019-nCoV in India: origin-based risk assessment in importation of infected travelers
The recent pandemic caused by the 2019 outbreak of novel coronavirus (2019-nCoV or COVID-19) has affected more than 3.0 million people resulting...
-
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
It has been known that, the novel coronavirus, 2019-nCoV, which is considered similar to SARS-CoV, invades human cells via the receptor angiotensin...
-
-
-
Analysis of 4 cases of children with false-positive results of novel coronavirus-specific antibody
BackgroundThis study attempts to explore the influencing factors and solutions of the colloidal gold method for novel coronavirus...
-
-
Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial
IntroductionThe waning antibody levels several months after prime vaccination and the persistent epidemics of severe acute respiratory syndrome...
